These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18805696)

  • 21. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
    Sechi M; Rizzi G; Bacchi A; Carcelli M; Rogolino D; Pala N; Sanchez TW; Taheri L; Dayam R; Neamati N
    Bioorg Med Chem; 2009 Apr; 17(7):2925-35. PubMed ID: 19026554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo design and synthesis of HIV-1 integrase inhibitors.
    Makhija MT; Kasliwal RT; Kulkarni VM; Neamati N
    Bioorg Med Chem; 2004 May; 12(9):2317-33. PubMed ID: 15080929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I/M154I mutant.
    Garvey EP; Schwartz B; Gartland MJ; Lang S; Halsey W; Sathe G; Carter HL; Weaver KL
    Biochemistry; 2009 Feb; 48(7):1644-53. PubMed ID: 19178153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and structure-activity relationship studies of a unique class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Neamati N
    ChemMedChem; 2006 Feb; 1(2):238-44. PubMed ID: 16892356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
    Deng J; Sanchez T; Al-Mawsawi LQ; Dayam R; Yunes RA; Garofalo A; Bolger MB; Neamati N
    Bioorg Med Chem; 2007 Jul; 15(14):4985-5002. PubMed ID: 17502148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
    Garofalo A; Grande F; Brizzi A; Aiello F; Dayam R; Neamati N
    ChemMedChem; 2008 Jun; 3(6):986-90. PubMed ID: 18383063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.
    Thaisrivongs S; Romero DL; Tommasi RA; Janakiraman MN; Strohbach JW; Turner SR; Biles C; Morge RR; Johnson PD; Aristoff PA; Tomich PK; Lynn JC; Horng MM; Chong KT; Hinshaw RR; Howe WJ; Finzel BC; Watenpaugh KD
    J Med Chem; 1996 Nov; 39(23):4630-42. PubMed ID: 8917652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and anti-integrase activity of catechol-DKA hybrids.
    Maurin C; Bailly F; Mbemba G; Mouscadet JF; Cotelle P
    Bioorg Med Chem; 2006 May; 14(9):2978-84. PubMed ID: 16412645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors.
    Johnson TW; Tanis SP; Butler SL; Dalvie D; Delisle DM; Dress KR; Flahive EJ; Hu Q; Kuehler JE; Kuki A; Liu W; McClellan GA; Peng Q; Plewe MB; Richardson PF; Smith GL; Solowiej J; Tran KT; Wang H; Yu X; Zhang J; Zhu H
    J Med Chem; 2011 May; 54(9):3393-417. PubMed ID: 21446745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors.
    Lee SU; Shin CG; Lee CK; Lee YS
    Eur J Med Chem; 2007 Oct; 42(10):1309-15. PubMed ID: 17434650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses.
    Le G; Vandegraaff N; Rhodes DI; Jones ED; Coates JA; Lu L; Li X; Yu C; Feng X; Deadman JJ
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5013-8. PubMed ID: 20685117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors.
    Wai JS; Kim B; Fisher TE; Zhuang L; Embrey MW; Williams PD; Staas DD; Culberson C; Lyle TA; Vacca JP; Hazuda DJ; Felock PJ; Schleif WA; Gabryelski LJ; Jin L; Chen IW; Ellis JD; Mallai R; Young SD
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5595-9. PubMed ID: 17822898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function.
    Billamboz M; Bailly F; Lion C; Touati N; Vezin H; Calmels C; Andréola ML; Christ F; Debyser Z; Cotelle P
    J Med Chem; 2011 Mar; 54(6):1812-24. PubMed ID: 21366258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
    Li HY; Zawahir Z; Song LD; Long YQ; Neamati N
    J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tricyclic HIV integrase inhibitors V. SAR studies on the benzyl moiety.
    Jin H; Metobo S; Jabri S; Mish M; Lansdown R; Chen X; Tsiang M; Wright M; Kim CU
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2263-5. PubMed ID: 19285389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Styrylquinazoline derivatives as HIV-1 integrase inhibitors.
    Lee JY; Park JH; Lee SJ; Park H; Lee YS
    Arch Pharm (Weinheim); 2002 Jun; 335(6):277-82. PubMed ID: 12210770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates--a new class of HIV-1 integrase inhibitors.
    Donghi M; Kinzel OD; Summa V
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1930-4. PubMed ID: 19269170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferrocenyl chalcone difluoridoborates inhibit HIV-1 integrase and display low activity towards cancer and endothelial cells.
    Monserrat JP; Al-Safi RI; Tiwari KN; Quentin L; Chabot GG; Vessières A; Jaouen G; Neamati N; Hillard EA
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6195-7. PubMed ID: 21889342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies.
    Mugnaini C; Rajamaki S; Tintori C; Corelli F; Massa S; Witvrouw M; Debyser Z; Veljkovic V; Botta M
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5370-3. PubMed ID: 17716893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid phase synthesis of novel pyrrolidinedione analogs as potent HIV-1 integrase inhibitors.
    Pendri A; Troyer TL; Sofia MJ; Walker MA; Naidu BN; Banville J; Meanwell NA; Dicker I; Lin Z; Krystal M; Gerritz SW
    J Comb Chem; 2010; 12(1):84-90. PubMed ID: 19902958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.